Piper Sandler Reiterates Neutral Rating on Collegium Pharmaceutical (COLL)
Tweet Send to a Friend
Piper Sandler analyst David Amsellem reiterated a Neutral rating and $37.00 price target on Collegium Pharmaceutical (NASDAQ: COLL).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
